Dashboard
Manage Tickers

RAPTRAPT Therapeutics, Inc.

Nasdaq rapt.com


$ 7.87 $ 0.07 (0.9 %)    

Friday, 19-Apr-2024 15:39:24 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 413.81 $ -9.38 (-2.22 %)
DIA $ 379.34 $ 0.86 (0.23 %)
SPY $ 494.44 $ -4.99 (-1 %)
TLT $ 89.07 $ -0.28 (-0.31 %)
GLD $ 221.38 $ 1.33 (0.6 %)
$ 7.93
$ 7.80
$ 7.86 x 200
$ 7.88 x 100
$ 7.63 - $ 7.88
$ 6.86 - $ 27.35
709,867
na
304.02M
$ 1.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-14-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 12-11-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-neutral-on-rapt-therapeutics
HC Wainwright & Co. Reiterates Neutral on ...
04/10/2024 10:19:57

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates RAPT Therapeutics (NASDAQ:RAPT) with a Neutral.

rapt-therapeutics-highlights-results-from-phase-2-trial-of-tivumecirnon-in-combination-with-anti-pd-1-immunotherapy-in-cpi-experienced-head-and-neck-cancer-patients
RAPT Therapeutics Highlights Results From ...
04/09/2024 16:01:38

- Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status - Confirmed ORR of 17.4% i...

jp-morgan-maintains-neutral-on-rapt-therapeutics-lowers-price-target-to-13
JP Morgan Maintains Neutral on RAPT Therap...
03/27/2024 14:44:03

JP Morgan analyst Anupam Rama maintains RAPT Therapeutics (NASDAQ:RAPT) with a Neutral and lowers the price target from $15 ...

rapt-therapeutics-q4-earnings-insights
RAPT Therapeutics: Q4 Earnings Insights
03/07/2024 14:25:06

rapt-therapeutics-q4-eps-080-beats-086-estimate-cash-balance-of-1589m-as-of-december-31-2023
RAPT Therapeutics Q4 EPS $(0.80) Beats $(0...
03/07/2024 13:06:20

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(0...

rapt-therapeutics-announces-multiple-late-breaking-presentations-at-the-upcoming-american-association-for-cancer-research-annual-meeting
RAPT Therapeutics Announces Multiple Late-...
03/05/2024 21:34:13

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developi...

ubs-downgrades-rapt-therapeutics-to-neutral-lowers-price-target-to-10
UBS Downgrades RAPT Therapeutics to Neutra...
02/22/2024 12:37:11

UBS analyst Eliana Merle downgrades RAPT Therapeutics (NASDAQ:RAPT) from Buy to Neutral and lowers the price target from $61...

rivian-automotive-reports-q4-loss-joins-etsy-lucid-group-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Rivian Automotive Reports Q4 Loss, Joins E...
02/22/2024 10:28:00

U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 2% on Thursday.

whats-going-on-with-rapt-therapeutics-stock-on-wednesday
What's Going On With RAPT Therapeutics Sto...
02/21/2024 19:04:57

Latest developments in RAPT Therapeutics as FDA places clinical hold on Phase 2b trial for zelnecirnon in dermatitis and asthma...

why-international-flavors--fragrances-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why International Flavors & Fragrances Sha...
02/21/2024 18:50:15

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/21/2024 17:31:07

correction-rapt-therapeutics-shares-are-trading-higher
CORRECTION: RAPT Therapeutics shares are t...
02/21/2024 16:39:55

leerink-partners-downgrades-rapt-therapeutics-to-market-perform-announces-10-price-target
Leerink Partners Downgrades RAPT Therapeut...
02/21/2024 12:21:16

Leerink Partners analyst Thomas Smith downgrades RAPT Therapeutics (NASDAQ:RAPT) from Outperform to Market Perform and annou...

hc-wainwright--co-downgrades-rapt-therapeutics-to-neutral
HC Wainwright & Co. Downgrades RAPT Therap...
02/21/2024 11:42:28

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades RAPT Therapeutics (NASDAQ:RAPT) from Buy to Neutral.

crude-oil-moves-lower-summit-therapeutics-shares-plummet
Crude Oil Moves Lower; Summit Therapeutics...
02/20/2024 19:33:12

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow trad...

cantor-fitzgerald-downgrades-rapt-therapeutics-to-neutral
Cantor Fitzgerald Downgrades RAPT Therapeu...
02/20/2024 19:14:19

Cantor Fitzgerald analyst Prakhar Agrawal downgrades RAPT Therapeutics (NASDAQ:RAPT) from Overweight to Neutral.

why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Fluor Shares Are Trading Lower By Arou...
02/20/2024 18:21:11

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
02/20/2024 17:31:11

why-is-inflammatory-diseaseoncology-focused-rapt-therapeutics-shares-tumbling-today
Why Is Inflammatory Disease/Oncology-Focus...
02/20/2024 17:24:06

FDA places clinical hold on RAPT Therapeutics' Phase 2 trials for zelnecirnon in atopic dermatitis and asthma.

dow-dips-over-100-points-us-leading-economic-index-falls-in-january
Dow Dips Over 100 Points; US Leading Econo...
02/20/2024 17:09:45

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)